While MR analysis, which utilizes GWAS data comparing cancer patients to healthy controls at the population level, suggests that IER3 expression is associated with reduced CRC risk, our single-cell analysis demonstrates that IER3+ SSCs within established tumors exhibit enhanced pro-tumorigenic characteristics. Here, IER3 is linked to cancer.